Literature DB >> 20208031

Heterologous expression of the oxytetracycline biosynthetic pathway in Myxococcus xanthus.

D Cole Stevens1, Michael R Henry, Kimberly A Murphy, Christopher N Boddy.   

Abstract

New natural products for drug discovery may be accessed by heterologous expression of bacterial biosynthetic pathways in metagenomic DNA libraries. However, a "universal" host is needed for this experiment. Herein, we show that Myxococcus xanthus is a potential "universal" host for heterologous expression of polyketide biosynthetic gene clusters.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20208031      PMCID: PMC2849223          DOI: 10.1128/AEM.02841-09

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  24 in total

1.  Phylogenetic analysis of polyketide synthase I domains from soil metagenomic libraries allows selection of promising clones.

Authors:  Aurélien Ginolhac; Cyrille Jarrin; Benjamin Gillet; Patrick Robe; Petar Pujic; Karine Tuphile; Hélène Bertrand; Timothy M Vogel; Guy Perrière; Pascal Simonet; Renaud Nalin
Journal:  Appl Environ Microbiol       Date:  2004-09       Impact factor: 4.792

Review 2.  Polyketide and nonribosomal peptide antibiotics: modularity and versatility.

Authors:  Christopher T Walsh
Journal:  Science       Date:  2004-03-19       Impact factor: 47.728

3.  Effects of growth medium, inoculum size, and incubation time on culturability and isolation of soil bacteria.

Authors:  Kathryn E R Davis; Shayne J Joseph; Peter H Janssen
Journal:  Appl Environ Microbiol       Date:  2005-02       Impact factor: 4.792

4.  Cloning and heterologous expression of the epothilone gene cluster.

Authors:  L Tang; S Shah; L Chung; J Carney; L Katz; C Khosla; B Julien
Journal:  Science       Date:  2000-01-28       Impact factor: 47.728

Review 5.  Measurement of in situ activities of nonphotosynthetic microorganisms in aquatic and terrestrial habitats.

Authors:  J T Staley; A Konopka
Journal:  Annu Rev Microbiol       Date:  1985       Impact factor: 15.500

6.  Heterologous expression of a myxobacterial natural products assembly line in pseudomonads via red/ET recombineering.

Authors:  Silke C Wenzel; Frank Gross; Youming Zhang; Jun Fu; A Francis Stewart; Rolf Müller
Journal:  Chem Biol       Date:  2005-03

7.  Evidence that asgB encodes a DNA-binding protein essential for growth and development of Myxococcus xanthus.

Authors:  L Plamann; J M Davis; B Cantwell; J Mayor
Journal:  J Bacteriol       Date:  1994-04       Impact factor: 3.490

8.  Engineered biosynthesis of a complete macrolactone in a heterologous host.

Authors:  C M Kao; L Katz; C Khosla
Journal:  Science       Date:  1994-07-22       Impact factor: 47.728

Review 9.  Myxobacteria: proficient producers of novel natural products with various biological activities--past and future biotechnological aspects with the focus on the genus Sorangium.

Authors:  Klaus Gerth; Silke Pradella; Olena Perlova; Stefan Beyer; Rolf Müller
Journal:  J Biotechnol       Date:  2003-12-19       Impact factor: 3.307

10.  Rapid cloning and heterologous expression of the meridamycin biosynthetic gene cluster using a versatile Escherichia coli-streptomyces artificial chromosome vector, pSBAC.

Authors:  Hongbo Liu; Hao Jiang; Bradley Haltli; Kerry Kulowski; Elwira Muszynska; Xidong Feng; Mia Summers; Mairead Young; Edmund Graziani; Frank Koehn; Guy T Carter; Min He
Journal:  J Nat Prod       Date:  2009-03-27       Impact factor: 4.050

View more
  13 in total

1.  Engineering Pseudochelin Production in Myxococcus xanthus.

Authors:  Juliane Korp; Lea Winand; Angela Sester; Markus Nett
Journal:  Appl Environ Microbiol       Date:  2018-10-30       Impact factor: 4.792

Review 2.  Synthetic biology of antimicrobial discovery.

Authors:  Bijan Zakeri; Timothy K Lu
Journal:  ACS Synth Biol       Date:  2012-12-04       Impact factor: 5.110

Review 3.  Oxytetracycline biosynthesis.

Authors:  Lauren B Pickens; Yi Tang
Journal:  J Biol Chem       Date:  2010-06-03       Impact factor: 5.157

4.  Heterologous expression and manipulation of three tetracycline biosynthetic pathways.

Authors:  Peng Wang; Woncheol Kim; Lauren B Pickens; Xue Gao; Yi Tang
Journal:  Angew Chem Int Ed Engl       Date:  2012-09-28       Impact factor: 15.336

Review 5.  Genetic platforms for heterologous expression of microbial natural products.

Authors:  Jia Jia Zhang; Xiaoyu Tang; Bradley S Moore
Journal:  Nat Prod Rep       Date:  2019-06-14       Impact factor: 13.423

6.  High-Titer Production of the Fungal Anhydrotetracycline, TAN-1612, in Engineered Yeasts.

Authors:  Pedro A Baldera-Aguayo; Arden Lee; Virginia W Cornish
Journal:  ACS Synth Biol       Date:  2022-06-14       Impact factor: 5.249

7.  MultiMetEval: comparative and multi-objective analysis of genome-scale metabolic models.

Authors:  Piotr Zakrzewski; Marnix H Medema; Albert Gevorgyan; Andrzej M Kierzek; Rainer Breitling; Eriko Takano
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

Review 8.  Biotechnology of polyketides: new breath of life for the novel antibiotic genetic pathways discovery through metagenomics.

Authors:  Elisângela Soares Gomes; Viviane Schuch; Eliana Gertrudes de Macedo Lemos
Journal:  Braz J Microbiol       Date:  2014-03-10       Impact factor: 2.476

9.  Heterologous Production of the Marine Myxobacterial Antibiotic Haliangicin and Its Unnatural Analogues Generated by Engineering of the Biochemical Pathway.

Authors:  Yuwei Sun; Zhiyang Feng; Tomohiko Tomura; Akira Suzuki; Seishi Miyano; Takashi Tsuge; Hitoshi Mori; Joo-Won Suh; Takashi Iizuka; Ryosuke Fudou; Makoto Ojika
Journal:  Sci Rep       Date:  2016-02-26       Impact factor: 4.379

10.  Alternative sigma factor over-expression enables heterologous expression of a type II polyketide biosynthetic pathway in Escherichia coli.

Authors:  David Cole Stevens; Kyle R Conway; Nelson Pearce; Luis Roberto Villegas-Peñaranda; Anthony G Garza; Christopher N Boddy
Journal:  PLoS One       Date:  2013-05-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.